BIOLETTO, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 1.582
AS - Asia 1.077
EU - Europa 1.055
SA - Sud America 414
OC - Oceania 30
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.184
Nazione #
US - Stati Uniti d'America 1.410
IT - Italia 324
SG - Singapore 315
CN - Cina 297
BR - Brasile 199
JP - Giappone 142
IE - Irlanda 134
MX - Messico 120
DE - Germania 89
SE - Svezia 76
ES - Italia 73
GB - Regno Unito 63
CL - Cile 53
FR - Francia 45
HK - Hong Kong 43
ID - Indonesia 42
NL - Olanda 41
PE - Perù 41
CO - Colombia 40
AR - Argentina 39
CA - Canada 38
TR - Turchia 38
BE - Belgio 33
EC - Ecuador 33
IN - India 33
TW - Taiwan 30
AU - Australia 26
IL - Israele 25
PL - Polonia 24
GR - Grecia 22
FI - Finlandia 20
PT - Portogallo 20
TH - Thailandia 19
VN - Vietnam 19
CH - Svizzera 15
RU - Federazione Russa 15
MY - Malesia 14
SA - Arabia Saudita 14
KR - Corea 13
DK - Danimarca 12
OM - Oman 12
EE - Estonia 8
HR - Croazia 8
NG - Nigeria 8
NO - Norvegia 8
UA - Ucraina 8
CZ - Repubblica Ceca 7
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 5
IR - Iran 5
PY - Paraguay 5
AT - Austria 3
DO - Repubblica Dominicana 3
FJ - Figi 3
GT - Guatemala 3
IQ - Iraq 3
VE - Venezuela 3
AO - Angola 2
EG - Egitto 2
GE - Georgia 2
HN - Honduras 2
MO - Macao, regione amministrativa speciale della Cina 2
RS - Serbia 2
TT - Trinidad e Tobago 2
TZ - Tanzania 2
ZM - Zambia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
SV - El Salvador 1
TC - Turks e Caicos 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.184
Città #
Chandler 271
Singapore 263
Santa Clara 226
Dublin 134
Turin 103
Nyköping 61
Ashburn 59
Columbus 47
Jakarta 33
Lima 32
São Paulo 32
Santiago 29
Torino 28
Medford 27
Salvador 25
Beijing 24
Shanghai 23
Tokyo 23
Milan 22
Princeton 22
Fairfield 21
Mexico City 20
Niterói 20
Guangzhou 18
Brussels 17
Los Angeles 17
Madrid 16
Buenos Aires 15
Istanbul 15
Medellín 14
Bangkok 13
Hangzhou 13
Hebei 13
Hong Kong 13
Quito 13
Recife 13
Tlalpan 13
Fortaleza 12
Helsinki 12
Paris 12
Wilmington 12
Cuenca 11
Guadalajara 11
Rotterdam 11
Taipei 11
Adelaide 10
Chengdu 10
London 10
Monterrey 10
Nanjing 10
New York 10
Rome 10
Barcelona 9
Guayaquil 9
Leipzig 9
Melbourne 9
Muscat 9
Seattle 9
Seoul 9
Toronto 9
Abuja 8
Bogotá 8
Cambridge 8
Central 8
Curitiba 8
Hamburg 8
Louisville 8
Osaka 8
Shenyang 8
Tallinn 8
Tel Aviv 8
Zagreb 8
Berlin 7
Boston 7
Cologne 7
Dammam 7
João Pessoa 7
Lappeenranta 7
Lewisville 7
Santiago de Cali 7
São José dos Campos 7
Tainan City 7
Washington 7
Zurich 7
Chicago 6
Florianópolis 6
Ho Chi Minh City 6
Iztapalapa 6
Krasnodar 6
Kyoto 6
Lisbon 6
Münster 6
Otemae 6
Porto Alegre 6
Prato 6
Rio de Janeiro 6
São Leopoldo 6
Valencia 6
Warsaw 6
Wenzhou 6
Totale 2.258
Nome #
The incidence of the refeeding syndrome. A systematic review and meta-analyses of literature 1.587
Impact of Refeeding Syndrome on Short- and Medium-Term All-Cause Mortality: A Systematic Review and Meta-Analysis 288
Traumatic Brain Injury as Frequent Cause of Hypopituitarism and Growth Hormone Deficiency: Epidemiology, Diagnosis, and Treatment 106
Efficacy of Teduglutide for Parenteral Support Reduction in Patients with Short Bowel Syndrome: A Systematic Review and Meta-Analysis 90
Mediterranean diet and sars-cov-2 infection: Is there any association? a proof-of-concept study 88
Development and validation of a scoring system for pre-surgical and early post-surgical prediction of bariatric surgery unsuccess at 2 years 87
Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension 82
Development and internal validation of a predictive model for the estimation of pheochromocytoma recurrence risk after radical surgery 82
Comparison of the diagnostic accuracy of 18F-Fluorocholine PET and 11C-Methionine PET for parathyroid localization in primary hyperparathyroidism: A systematic review and meta-analysis 80
Association of Urine Metanephrine Levels with Cardiometabolic Risk: An Observational Retrospective Study 79
From SGAP-Model to SGAP-Score: A Simplified Predictive Tool for Post-Surgical Recurrence of Pheochromocytoma 74
Mortality and parenteral nutrition weaning in patients with chronic intestinal failure on home parenteral nutrition: A 30-year retrospective cohort study 73
Long-Term Efficacy of Intensive Zoledronate Therapy and Predictors of Retreatment in Paget’s Disease of Bone 70
A New Clinical Model to Estimate the Pre-Test Probability of Cushing's Syndrome: The Cushing Score 67
Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight 66
Development and Internal Validation of a Predictive Model for Adult GH Deficiency Prior to Stimulation Tests 65
Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects 65
The Accuracy of Simple and Adjusted Aldosterone Indices for Assessing Selectivity and Lateralization of Adrenal Vein Sampling in the Diagnosis of Primary Aldosteronism Subtypes 64
THE CUT-OFF LIMITS OF GH RESPONSE TO INSULIN TOLERANCE TEST RELATED TO BODY MASS INDEX FOR THE DIAGNOSIS OF ADULT GH DEFICIENCY 63
Non-celiac gluten/wheat sensitivity: Clinical characteristics and microbiota and mycobiota composition by response to the gluten challenge test 62
The diagnostic accuracy of adjusted unconventional indices for adrenal vein sampling in the diagnosis of primary aldosteronism subtypes 60
Diabetic ketoacidosis in acromegaly: a case study—somatostatin analogs adverse event or disease complication? 55
Optimal timing of blood samplings to detect GH inhibition during oral glucose tolerance test 53
The effect of trehalose administration on vascular inflammation in patients with coronary artery disease 53
Are prolactin levels efficient in predicting a pituitary lesion in patients with hyperprolactinemia? 45
Adrenocortical, somatotropic, and antidiuretic response to nasal glucagon in healthy subjects. 45
A retrospective study on the association between urine metanephrines and cardiometabolic risk in patients with nonfunctioning adrenal incidentaloma 43
Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study 42
Neuroendocrine response to diclofenac in healthy subjects: a pilot study. 37
Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy 37
Clinical and Pathological Tools for Predicting Recurrence and/or Metastasis in Patients with Pheochromocytoma and Paraganglioma 37
Development and internal validation of a predictive score for the diagnosis of central adrenal insufficiency when morning cortisol is in the grey zone 36
Pathophysiology and Management of Glycemic Alterations before and after Surgery for Pheochromocytoma and Paraganglioma 34
Two-dimensional and three-dimensional cardiac magnetic resonance feature-tracking myocardial strain analysis in acute myocarditis patients with preserved ejection fraction 34
Psychiatric disorders and anger in patients with controlled acromegaly 33
Trabecular Bone Score as an Index of Bone Fragility in Patients with Acromegaly: A Systematic Review and Meta-Analysis. 33
Sex-specific fat mass ratio cutoff value identifies a high prevalence of cardio-metabolic disorders in people living with HIV 31
MRI Assessment of Cardiac Function and Morphology in Adult Patients With Growth Hormone Deficiency: A Systematic Review and Meta-Analysis 27
Long-term efficacy of empagliflozin as an add-on treatment for chronic SIAD: a case report and literature review 26
Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives 25
Radiomic Analysis in Pituitary Tumors: Current Knowledge and Future Perspectives 25
GHRH + arginine test and body mass index: do we need to review diagnostic criteria for GH deficiency? 25
Effectiveness of Copeptin, MR-proADM and MR-proANP in Predicting Adverse Outcomes, Alone and in Combination with Traditional Severity Scores, a Secondary Analysis in COVID-19 Patients Requiring Intensive Care Admission 23
Prediction of Early and Long-Term Hospital Readmission in Patients with Severe Obesity: A Retrospective Cohort Study 23
Isolated anterior pituitary dysfunction in adulthood 22
BONE SAFETY OF DUAL-RELEASE HYDROCORTISONE IN PATIENTS WITH AUTOIMMUNE PRIMARY ADRENAL INSUFFICIENCY 20
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center 19
Utility of copeptin in predicting non-pathological postoperative polyuria in patients affected by acromegaly undergoing pituitary neurosurgery. 16
Mild hyponatremia is not associated with degradation of trabecular bone microarchitecture despite bone mass loss. 16
Radiomic Analysis in Pituitary Tumors: Current Knowledge and Future Perspectives 15
Estimating Cardiovascular Benefits of Tirzepatide in Sleep Apnea and Obesity: Insight from the SURMOUNT-OSA Trials 13
null 12
Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience. 12
Excess mortality in patients with non-functioning pituitary adenoma: a systematic review and meta-analysis 11
Effect of Cabergoline on weight and glucose metabolism in patients with acromegaly. 10
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center 6
null 1
Totale 4.293
Categoria #
all - tutte 16.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 1 1 1 1 1
2020/202154 0 1 0 1 4 1 0 0 1 26 4 16
2021/2022342 37 9 11 11 29 12 10 16 27 26 92 62
2022/20231.294 60 141 39 113 91 170 91 85 136 97 124 147
2023/20241.308 138 122 85 87 93 121 99 114 42 121 141 145
2024/20251.290 80 174 131 283 424 198 0 0 0 0 0 0
Totale 4.293